Wolverine Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $236K | Hold |
|
|||||
|
2025
Q2 | $87.5K | Hold |
|
|||||
|
2025
Q1 | $128K | Buy |
|
|||||
|
2024
Q4 | $192K | Hold |
|
|||||
|
2024
Q3 | $144K | Hold |
|
|||||
|
2024
Q2 | $194K | Hold |
|
|||||
|
2024
Q1 | $234K | Hold |
|
|||||
|
2023
Q4 | $261K | Hold |
|
|||||
|
2023
Q3 | $85.6K | Hold |
|
|||||
|
2023
Q2 | $121K | Hold |
|
|||||
|
2023
Q1 | $139K | Hold |
|
|||||
|
2022
Q4 | $544K | Sell |
|
|||||
|
2022
Q3 | $973K | Sell |
|
|||||
|
2022
Q2 | $940K | Sell |
|
|||||
|
2022
Q1 | $694K | Buy |
|
|||||
|
2021
Q4 | $718K | Buy |
|
|||||
|
2021
Q3 | $1.39M | Buy |
|
|||||
|
2021
Q2 | $1.59M | Buy |
|
|||||
|
2021
Q1 | – | Hold |
|